ANIP vs MA · rev $503.5M vs P/E 38, rev $17.68B
ANI Pharmaceuticals Inc (ANIP) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
ANIP currently screens at market cap $1.41B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the ANIP and MA stock pages for the full models.
Not investment advice.